Stocksigma LogoStocksigma Logo

USFDA Concludes Inspection at Zydus Lifesciences' Ahmedabad SEZ II Facility

The USFDA conducted a current Good Manufacturing Practice (cGMP) inspection at Zydus Lifesciences' manufacturing facility located at SEZ II, Ahmedabad

USFDA Concludes Inspection at Zydus Lifesciences' Ahmedabad SEZ II Facility

Zydus Lifesciences Ltd 路 Press Release 路 28 Sept 2026, 11:35 pm

USFDA Concludes Inspection at Zydus Lifesciences' Ahmedabad SEZ II Facility The USFDA conducted a current Good Manufacturing Practice (cGMP) inspection at Zydus Lifesciences' manufacturing facility located at SEZ II, Ahmedabad, from 21st Sep'26 to 28th Sep'26. The inspection concluded with a single observation, with no data integrity-related issues identified. The company stated it will work closely with the USFDA to expeditiously address the observation.

Original exchange filing (PDF)

More announcements from Zydus Lifesciences Ltd

All Zydus Lifesciences Ltd announcements